Navigation Links
Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours
Date:6/18/2009

LAUSANNE, Switzerland and TAMPA, Florida, June 18 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Moffitt Cancer Center (Moffitt), a non-profit Florida corporation, announce the signature of an exclusive license agreement for the development and commercialization of Debio 0928, a small molecule in early preclinical development that inhibits the protein-protein interaction between Raf-1 (key signalling kinase in the MAP kinase pathway) and Rb (retinoblastoma protein). Rb acts as a barrier to cell division and proliferation. However, when Raf-1 physically interacts with Rb, it triggers a cascade of signals that eventually overcomes this barrier, thus inducing cellular proliferation. By preventing the interaction between Raf-1 and Rb and blocking the cell cycle, Debio 0928 creates a new strategy in the fight against cancer and is thus a potentially promising novel anti-tumour drug.

Under the terms of the agreement, Debiopharm shall pay Moffitt an up-front fee, as well as predefined advanced milestone payments during the development of Debio 0928. First entry of the product into man is expected for 2012.

"This discovery, made by the collaboration between Drs. Srikumar Chellappan, Said Sebti, and Nicholas Lawrence at Moffitt, is a novel approach to the treatment of cancer," said Rolland-Yves Mauvernay, President and Founder of Debiopharm Group. "Being able to de-activate a key signalling kinase like Raf-1, known to be involved in many types of cancer, could open the door to more effective oncology treatments in the future."

"The disruption of the binding of the tumour promoter Raf-1 to the tumour suppressor Rb with Debio 0928 is a novel, first-in-class therapeutic strategy that has the potential for targeting a wide spectrum of human cancers," added
'/>"/>

SOURCE Debiopharm Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions
2. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
3. Japanese Cancer Association and Debiopharm Honour Japanese Research
4. Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
5. Debiopharm and EPFL Establish an Oncology Chair
6. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
7. Debiopharm Receives cGMP Certification for Quality Control of its Drug Products
8. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
9. Digital Healthcare Specialist Cadient Group Ranked #2 on List of Full-service Advertising Agencies in the Philadelphia Region
10. PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
11. Cadient Group Brings Home the Gold and Two Bronze Aster Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- U.S. Secretary of State John Kerry today ...  scientist Mary-Dell Chilton , Ph.D., was named a ... prize is the foremost international award recognizing individuals who ... or availability of food in the world. ... "revolutionary biotechnology discoveries that unlocked the key to plant ...
(Date:6/19/2013)... MO BIO Laboratories, Inc., the leader ... nucleic acid purification, announces the launch of the ... pure protein from all soil types. This expansion ... th anniversary of the company and showcases ... http://photos.prnewswire.com/prnh/20130619/LA32633 ) The NoviPure™ ...
(Date:6/19/2013)... Today DuPont Executive Vice President ... leaders in the greatest challenge facing our time – ... Borel spoke at the International Food and ... urgent need for students to contribute their time and ... and reached in collaboration with others. , “Food is ...
(Date:6/19/2013)... 2013 India’s vast and growing ... be worth up to a billion dollars per ... government is taking serious action to better regulate ... This presentation will examine:, ,     Recent ...     Immediate and long term impacts ,     Foreseeable ...
Breaking Biology Technology:Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2
... Wis. - Imago Scientific Instruments Corp. , a ... materials, has won acclaim for the updated capabilities of its ... by Research and Development Magazine recently recognized the ... Tim Stultz, president and CEO of Imago, said the microscope, ...
... for Wisconsin governor are playing a game of one- upsmanship on ... turn to up the ante after Gov. Jim Doyle ... for ethanol. , ,Green, however, did not take that opportunity to ... he once voted for legislation to repeal the controversial law. Instead, ...
... - According to a recent article in Wisconsin Technology ... not only improve Wisconsin's business climate, but also put us ... of mutual cooperation and regional planning is what saved Denver ... ,Wait a minute. Wasn't Denver and all of Colorado reduced ...
Cached Biology Technology:Green doesnt up the ante on markup law 2Denver prospered because of "dreaded" TABOR 2Denver prospered because of "dreaded" TABOR 3
(Date:6/19/2013)... Tanzania is playing a vital role in the survival ... response to climate and environmental changes, according to new ... on savannah birds from the Tanzanian Bird Atlas project ... decades - the researchers found that they are using ... areas further west where dry seasons are getting longer, ...
(Date:6/19/2013)... study of the patients who received injections of ... the New England Compounding Center has found that ... did not experience a worsening of their symptoms ... detect infection, especially among those individuals who received ... study, along with an editorial by UC Davis ...
(Date:6/19/2013)... Montreal, June 19, 2013 A study published in ... is the first report of an oral probiotic supplement ... , The lead author on the study, ... Poster Presentation Prize from the New York Academy of ... last week,s Probiotics, Prebiotics, and the Host Microbiome: ...
Breaking Biology News(10 mins):Protected areas provide African birds with stepping stones to survival 2Evolution of an outbreak: Complications from contaminated steroid injections 2Study shows probiotic Lactobacillus reuteri NCIMB 30242 significantly increased vitamin D levels 2
... ... HARBOR, Fla., Dec. 2 Communication Intelligence Corporation ("CIC") ... signature solutions for business process automation in the financial ... and Docubase Systems Inc. ("Docubase"), a leading International Electronic ...
... NY, December 2, 2009 Commonly prescribed beta 2 adrenergic ... as well as pre-term labor may increase the incidence of ... in their children, according to a new study published in ... Obstetrics & Gynecology . Beta 2 adrenergic agonist drugs ...
... According to the National Institute of Health, 40 percent to ... stage of diabetic retinopathy. Diabetic retinopathy, damage to the ... of blindness in people with diabetes and is one of ... 80 percent of all patients who,ve had diabetes for 10 ...
Cached Biology News:CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3
... Band Purification Kit, 100. For the purification, isolation ... (0.1-10 kb) from solution and from TAE or ... solution in as little as 5 min or ... glass fiber matrix columns provide consistent results and ...
These disposable button tethers are designed for rat infusion studies lasting more than 2 weeks. After one to two weeks the subcutaneous tissue will grow into the Dacron mesh, making the sutures irre...
Newborn Bovine Serum Heat-Inactivated...
Mycoplasma and virus tested...
Biology Products: